In May, Blue Note Therapeutics was joined by clinical experts from MSKCC Dr. Allison J. Applebaum, Dr. William S. Breitbart, Dr. Wendy Lichtenthal, and Dr. Hayley Pessin, along with our patient advisors Anne Marie Mercurio and Michael Mancini to discuss the origins and treatments of cancer-related distress.
During Oncology Nursing Month, Blue Note Therapeutics had the opportunity to discuss cancer-related distress with Dr. Lisa Kennedy Sheldon, oncology nurse practitioner, cancer care advocate, and former CCO for the Oncology Nursing Society.
Nearly all patients living with cancer experience some form of cancer-related distress. Yet, less than half are referred to mental health specialists. Learn how one patient is inspiring Blue Note as he advocates for cancer awareness and mental health support.
In early 2021, Blue Note Therapeutics was joined by Dr. Patricia Ganz, MD, Dr. Areej El-Jawahri, MD, and Dr. Michael Antoni, PhD, to discuss advances in the field of psycho-oncology.
How one executive's nontraditional career path led to a new point of view on compassion and empathy.
Blue Note Therapeutics was founded with a commitment to involving patients in every step of its work to develop online mental health treatments for cancer-related distress. But what does that mean, exactly?